Progress of serogroup B meningococcal outer membrane vesicle vaccines.
10.3760/cma.j.cn112150-20220321-00265
- Author:
Meng Meng YUE
1
;
Juan XU
2
;
Li XU
2
;
Zhu Jun SHAO
1
Author Information
1. National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China School of Public Health, Nanjing Medical University, Nanjing 211166, China.
2. National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
- Publication Type:Journal Article
- MeSH:
Antigens, Bacterial;
Humans;
Meningococcal Infections/prevention & control*;
Meningococcal Vaccines;
Neisseria meningitidis, Serogroup B;
Serogroup;
Vaccines, Synthetic
- From:
Chinese Journal of Preventive Medicine
2022;56(9):1333-1340
- CountryChina
- Language:Chinese
-
Abstract:
This research and development of MenB meningococcal vaccines includes two technical routes: outer membrane vesicle (OMV) vaccines and recombinant protein vaccines. This article intends to review the development, production and application of MenB meningococcal OMV vaccines in order to provide a reference for the development of MenB meningococcal OMV vaccine in China.
